CWM
ATRS

Centric Wealth Management’s Antares Pharma, Inc. ATRS Stock Holding History

Centric Wealth Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,337,449
Closed -$13.7M – 223
2021
Q1 		$13.7M Sell
3,337,449
-143,860
-4% -$623K 3.92% 2
2020
Q4 		$13.9M Buy
+3,481,309
New +$11.3M 4.33% 2
2020
Q3 		– Sell
-3,594,849
Closed -$9.89M – 168
2020
Q2 		$9.89M Buy
+3,594,849
New +$10M 5.18% 2

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Centric Wealth Management's ATRS Position: Q2 2021 in Review

Centric Wealth Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2021, closing a stake of 3,337,449 shares — an estimated $13.7M sold.

Centric Wealth Management first reported a position in ATRS in Q2 2020 and held it in 3 quarters. The position peaked at $13.9M in Q4 2020. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.

  • Centric Wealth Management reported no remaining Antares Pharma, Inc. position as of Q2 2021 after selling out during the quarter.
  • Centric Wealth Management sold 3,337,449 Antares Pharma, Inc. shares in Q2 2021, an estimated $13.7M.
  • Centric Wealth Management first reported a position in Antares Pharma, Inc. in Q2 2020 and held it in 3 quarters.
  • Centric Wealth Management's Antares Pharma, Inc. position peaked at $13.9M in Q4 2020.
  • 175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.

Based on Centric Wealth Management's 13F filing for Q2 2021, filed 21 Jul 2021.